Bioventus Inc. cotiza a 13.57 USD y tiene una capitalización bursátil de $927M. En los últimos 12 meses ha facturado $582M con un margen de flujo de caja libre del 12.7%. Cotiza a 9.8 veces su flujo de caja libre (P/FCF) y a un PER de 17.0. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Bioventus Inc., a medical device company, focuses on relieving pain and addressing musculoskeletal therapies in the United States and internationally. The company's product portfolio includes pain treatments, which comprise various intra-articular and hyaluronic acid injections; peripheral nerve stimulation products, s…
| Métrica | BVS | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 68.3% | 57.0% | +11.3% |
| Operating Margin | 9.5% | -38.6% | +48.1% |
| Net Margin | 4.0% | -33.6% | +37.6% |
| FCF Margin | 12.7% | -13.9% | +26.5% |
| ROE | 12.3% | -40.4% | +52.8% |
| ROA | 3.3% | -32.0% | +35.3% |
| Current Ratio | 1.70 | 2.84 | -1.14 |
| Debt / Equity | 1.52 | 0.28 | +1.24 |